Business Description
Icecure Medical Ltd
ISIN : IL0011224156
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 18.47 | |||||
Equity-to-Asset | 0.74 | |||||
Debt-to-Equity | 0.05 | |||||
Debt-to-EBITDA | -0.04 | |||||
Interest Coverage | N/A | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -1.99 | |||||
Beneish M-Score | -3.2 | |||||
WACC vs ROIC |
Growth Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -32 | |||||
3-Year EBITDA Growth Rate | -12 | |||||
3-Year EPS without NRI Growth Rate | -13.3 | |||||
3-Year FCF Growth Rate | -7.7 | |||||
3-Year Book Growth Rate | -1.6 |
Momentum Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 34.06 | |||||
9-Day RSI | 39.6 | |||||
14-Day RSI | 42.65 | |||||
6-1 Month Momentum % | 43.92 | |||||
12-1 Month Momentum % | -7.81 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.66 | |||||
Quick Ratio | 3.08 | |||||
Cash Ratio | 2.86 | |||||
Days Inventory | 509.26 | |||||
Days Sales Outstanding | 12.43 | |||||
Days Payable | 139.34 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -31.3 | |||||
Shareholder Yield % | 0.23 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 40.26 | |||||
Operating Margin % | -482.38 | |||||
Net Margin % | -453.76 | |||||
FCF Margin % | -402.63 | |||||
ROE % | -78.93 | |||||
ROA % | -63.38 | |||||
ROIC % | -127.68 | |||||
ROC (Joel Greenblatt) % | -168.21 | |||||
ROCE % | -82.17 |
GF Value Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 17.04 | |||||
PB Ratio | 4.44 | |||||
Price-to-Tangible-Book | 4.44 | |||||
EV-to-EBIT | -2.82 | |||||
EV-to-EBITDA | -2.88 | |||||
EV-to-Revenue | 13.61 | |||||
EV-to-Forward-Revenue | 9.87 | |||||
EV-to-FCF | -3.38 | |||||
Price-to-Net-Current-Asset-Value | 5.45 | |||||
Price-to-Net-Cash | 8 | |||||
Earnings Yield (Greenblatt) % | -35.46 | |||||
FCF Yield % | -23.69 |